csj148
mAbexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 2, 2015 (NCT02268526)
Timeline
Indications
Studied for
Mechanism of action
- CytomegalovirusINHIBITOR
Cytomegalovirus inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- csj148
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03369912 | Phase 2 | Oct 23, 2018 | Novartis |
| NCT02268526 | Phase 1/Phase 2 (Phase 2) | Jun 2, 2015 | Novartis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 2 | 2 | 1 | 2015 |
1 organizations
Page 1 / 1